Literature DB >> 20687207

Glut1 deficiency: inheritance pattern determined by haploinsufficiency.

Michael Rotstein1, Kristin Engelstad, Hong Yang, Dong Wang, Brynn Levy, Wendy K Chung, Darryl C De Vivo.   

Abstract

Two families manifesting Glut1 deficiency syndrome (DS) as an autosomal recessive trait are described. In 1 family, a severely affected boy inherited a mutated allele from his asymptomatic heterozygous mother. A de novo mutation developed in the paternal allele, producing compound heterozygosity. In another family, 2 mildly affected sisters inherited mutations from their asymptomatic heterozygous consanguineous parents. Red blood cell glucose uptake residual activity, a surrogate of haploinsufficiency, correlated with the clinical severity. These cases demonstrate that Glut1 DS may present as an autosomal recessive trait. The clinical pattern of inheritance is determined by the relative pathogenicity of the mutation and the resulting degree of haploinsufficiency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20687207      PMCID: PMC2994988          DOI: 10.1002/ana.22088

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

Review 1.  Will the original glucose transporter isoform please stand up!

Authors:  Anthony Carruthers; Julie DeZutter; Amit Ganguly; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-18       Impact factor: 4.310

2.  Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome.

Authors:  D Wang; P Kranz-Eble; D C De Vivo
Journal:  Hum Mutat       Date:  2000-09       Impact factor: 4.878

3.  Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome.

Authors:  J Klepper; M Garcia-Alvarez; K R O'Driscoll; M K Parides; D Wang; Y Y Ho; D C De Vivo
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

4.  Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects.

Authors:  Dong Wang; Juan M Pascual; Hong Yang; Kristin Engelstad; Sarah Jhung; Ruo Peng Sun; Darryl C De Vivo
Journal:  Ann Neurol       Date:  2005-01       Impact factor: 10.422

5.  Autosomal dominant glut-1 deficiency syndrome and familial epilepsy.

Authors:  K Brockmann; D Wang; C G Korenke; A von Moers; Y Y Ho; J M Pascual; K Kuang; H Yang; L Ma; P Kranz-Eble; J Fischbarg; F Hanefeld; D C De Vivo
Journal:  Ann Neurol       Date:  2001-10       Impact factor: 10.422

6.  Functional studies of threonine 310 mutations in Glut1: T310I is pathogenic, causing Glut1 deficiency.

Authors:  Dong Wang; Juan M Pascual; Pavel Iserovich; Hong Yang; Li Ma; Kunyan Kuang; Felipe A Zuniga; Ruo Peng Sun; Kavita M Swaroop; Jorge Fischbarg; Darryl C De Vivo
Journal:  J Biol Chem       Date:  2003-09-16       Impact factor: 5.157

7.  Cerebral lactic acidosis correlates with neurological impairment in MELAS.

Authors:  P Kaufmann; D C Shungu; M C Sano; S Jhung; K Engelstad; E Mitsis; X Mao; S Shanske; M Hirano; S DiMauro; D C De Vivo
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

8.  A mouse model for Glut-1 haploinsufficiency.

Authors:  Dong Wang; Juan M Pascual; Hong Yang; Kristin Engelstad; Xia Mao; Jianfeng Cheng; Jong Yoo; Jeffrey L Noebels; Darryl C De Vivo
Journal:  Hum Mol Genet       Date:  2006-02-23       Impact factor: 6.150

9.  The glucose transporter of the human brain and blood-brain barrier.

Authors:  R N Kalaria; S A Gravina; J W Schmidley; G Perry; S I Harik
Journal:  Ann Neurol       Date:  1988-12       Impact factor: 10.422

10.  Analysis of the structural features of the C-terminus of GLUT1 that are required for transport catalytic activity.

Authors:  A Muraoka; M Hashiramoto; A E Clark; L C Edwards; H Sakura; T Kadowaki; G D Holman; M Kasuga
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

View more
  24 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

Review 2.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

Review 3.  Epileptic encephalopathies: new genes and new pathways.

Authors:  Sahar Esmaeeli Nieh; Elliott H Sherr
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

4.  Dietary Treatments and New Therapeutic Perspective in GLUT1 Deficiency Syndrome.

Authors:  Pierangelo Veggiotti; Valentina De Giorgis
Journal:  Curr Treat Options Neurol       Date:  2014-05       Impact factor: 3.598

5.  A Cause of Permanent Ketosis: GLUT-1 Deficiency.

Authors:  Alexis Chenouard; Sandrine Vuillaumier-Barrot; Nathalie Seta; Alice Kuster
Journal:  JIMD Rep       Date:  2014-09-26

Review 6.  Paroxysmal Movement Disorders: Recent Advances.

Authors:  Zheyu Xu; Che-Kang Lim; Louis C S Tan; Eng-King Tan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-11       Impact factor: 5.081

7.  Implications of aberrant temperature-sensitive glucose transport via the glucose transporter deficiency mutant (GLUT1DS) T295M for the alternate-access and fixed-site transport models.

Authors:  Philip Cunningham; Richard J Naftalin
Journal:  J Membr Biol       Date:  2013-06-06       Impact factor: 1.843

Review 8.  Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS).

Authors:  Toni S Pearson; Cigdem Akman; Veronica J Hinton; Kristin Engelstad; Darryl C De Vivo
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

Review 9.  Epileptic Encephalopathy in Childhood: A Stepwise Approach for Identification of Underlying Genetic Causes.

Authors:  Jaina Patel; Saadet Mercimek-Mahmutoglu
Journal:  Indian J Pediatr       Date:  2016-01-29       Impact factor: 1.967

Review 10.  Glucose transporters in brain in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-13       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.